603669.SH
灵康药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 5.39
−1.64%Margins
Gross margin
42.3%
EBITDA margin
-45.0%
EBIT margin
-48.6%
Net margin
-47.8%
FCF margin
-42.5%
-27.5%
Return on equity
-15.3%
Return on assets
-26.5%
Return on invested capital
0.32x
Asset turnover
-CNY 148.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026